Inotuzumab ozogamicin (CMC-544) compared to chemotherapy in patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL): A retrospective comparison
被引:0
作者:
Faderl, Stefan
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Faderl, Stefan
Jain, Nitin
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Jain, Nitin
O'Brien, Susan Mary
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
O'Brien, Susan Mary
Thomas, Deborah A.
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Thomas, Deborah A.
Ravandi, Farhad
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Ravandi, Farhad
Jabbour, Elias
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Jabbour, Elias
Pierce, Sherry
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Pierce, Sherry
Kantarjian, Hagop M.
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
Kantarjian, Hagop M.
机构:
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA